Theravance Biopharma (TBPH) Receivables - Other (2013 - 2026)
Theravance Biopharma's Receivables - Other was $20.38 million in Q2 2026, down 7.0% from $21.92 million a year earlier but up 30.8% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Receivables - Other (2013 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Other at Theravance Biopharma came in at $45.54 million, up 147.0% from FY2024.
- Receivables - Other has now increased for three consecutive years, though with a five-year compound annual growth rate of -3.3% (FY2020 to FY2025).
- In earlier years, Receivables - Other was $18.44 million in FY2024 (+5.5%), $17.47 million in FY2023 (+4.1%), $16.79 million in FY2022 (-61.4%) and $43.5 million in FY2021 (-19.1%).
- Quarterly Receivables - Other has moved between $12.27 million (Q1 2023) and $45.54 million (Q4 2025) over five years.
- Compared with a year earlier, Receivables - Other was higher in six of the last eight quarters, with growth averaging 26.5%.
- The best year-over-year quarter for Receivables - Other over five years was Q4 2025 (growth of 147.0%); the worst was Q3 2022 (a decline of 67.8%).
- Per Business Quant data, TBPH's Receivables - Other in the three quarters before Q2 2026 was $15.58 million (Q1 2026), $45.54 million (Q4 2025) and $18.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.38 Mn |
| Mar 31, 2026 | 15.58 Mn |
| Dec 31, 2025 | 45.54 Mn |
| Sep 30, 2025 | 18.27 Mn |
| Jun 30, 2025 | 21.92 Mn |
| Mar 31, 2025 | 15.35 Mn |
| Dec 31, 2024 | 18.44 Mn |
| Sep 30, 2024 | 16.85 Mn |
| Jun 30, 2024 | 14.30 Mn |
| Mar 31, 2024 | 14.66 Mn |
| Dec 31, 2023 | 17.47 Mn |
| Sep 30, 2023 | 17.06 Mn |
| Jun 30, 2023 | 15.80 Mn |
| Mar 31, 2023 | 12.27 Mn |
| Dec 31, 2022 | 16.79 Mn |
| Sep 30, 2022 | 14.11 Mn |
| Jun 30, 2022 | 12.49 Mn |
| Mar 31, 2022 | 35.56 Mn |
| Dec 31, 2021 | 43.50 Mn |
| Sep 30, 2021 | 43.77 Mn |
API Access
Theravance Biopharma Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();